Longview Asset Management Likes These Stocks

Longview Asset Management, formerly known as Longview Management Group, is a Chicago-based investment fund managed by James Star which invests in publicly traded U.S. equities. The fund’s 13F filings generally show only a small number of positions, suggesting that the fund either has considerable positions which it does not need to disclose publicly or prefers to focus its attention on a small number of stocks. According to the 13F for the second quarter (research changes in Longview’s portfolio over time), here were the fund’s four positions at the end of June:

Warren Buffett

Talk about a confidence pick: 77% of Longview’s 13F portfolio was invested in General Dynamics Corporation (NYSE:GD), which provides combat vehicles, weapons systems, and shipbuilding capabilities to the U.S. military alongside its aerospace operations. The fund owned 33 million shares at the end of June, essentially unchanged from a year ago. General Dynamics is down 3% so far in 2012 against a rising market as investors worry about the impact of lower military spending on the company’s business. If spending cuts do not come to pass- and increasing unrest throughout the world has begun to put some pressure on Washington to maintain existing spending- the stock should rise accordingly. General Dynamics trades at only 10 times trailing earnings despite its $23 billion market capitalization and 3.1% dividend yield. Its forward P/E is 9 as the sell-side actually expects higher EPS for next year. Warren Buffett’s Berkshire Hathaway also owned shares of General Dynamics at the end of the second quarter, with the holding company’s 3.9 million shares being unchanged from the beginning of April (see more stocks in Warren Buffett’s portfolio). For comparison, larger aerospace and defense company The Boeing Company (NYSE:BA) has trailing and forward P/Es of 12 and a lower dividend yield at 2.5%. Of course, Boeing’s business has a good deal of concentration on aerospace.

The second largest position in Longview’s 13F portfolio, with 6.9 million shares, was a bit different from a defense contractor: $7.4 billion market cap pet supply retailer PetSmart Inc. (NASDAQ:PETM), which has broadened its service offerings into pet boarding houses and veterinary hospitals. PetSmart is quite defensive at a beta of 0.6- people spend roughly the same amount on their pets regardless of economic conditions- and pays a small dividend yield of 1% as the company focuses on growth. Earnings were up 28% last quarter compared to the same period a year ago, and the company currently trades at 23 times trailing earnings. It’s not a value stock, but could be a candidate for growth-at-a-reasonable-price status.

The fund initiated a position of 2.8 million shares in Polypore International Inc. (NYSE:PPO) between April and June. Polypore is a $1.6 billion market cap developer and manufacturer of specialized membranes that are used in batteries and high-tech filtration systems. Polypore has been slipping recently- its earnings last quarter were down 31% from the same quarter last year, and revenue was down as well. The stock price has dropped 41% since a year ago. Generation Investment Management, managed by David Blood and Al Gore, more than doubled its own stake in Polypore during the second quarter to a total of 1.3 million shares.

Thermon Group Holdings Inc (NYSE:THR) was the last of Longview’s stock picks according to the 13F. Star and his team maintained a position of 2.8 million shares of the provider of heating and heat tracing cables. Thermon Group has beaten earnings expectations for each of the last four quarters, with analyst consensus for the fiscal year ending in March 2014 implying a fairly reasonable forward P/E of 19 (the company trades at 33 times trailing earnings). If the sell-side is correct- or if they are once again underestimating Thermon Group’s prospects- it could end up being a potential growth stock.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!